Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Change in Cash (2020 - 2025)

HCW Biologics (HCWB) has disclosed Change in Cash for 6 consecutive years, with -$1.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash fell 722.88% year-over-year to -$1.3 million, compared with a TTM value of $98688.0 through Sep 2025, up 100.97%, and an annual FY2024 reading of $1.1 million, up 105.76% over the prior year.
  • Change in Cash was -$1.3 million for Q3 2025 at HCW Biologics, down from $1.3 million in the prior quarter.
  • Across five years, Change in Cash topped out at $10.8 million in Q3 2022 and bottomed at -$10.9 million in Q2 2023.
  • Average Change in Cash over 5 years is -$387311.8, with a median of -$1.6 million recorded in 2021.
  • The sharpest move saw Change in Cash skyrocketed 499.23% in 2022, then plummeted 829.48% in 2025.
  • Year by year, Change in Cash stood at -$3.4 million in 2021, then dropped by 14.83% to -$3.9 million in 2022, then tumbled by 95.64% to -$7.6 million in 2023, then soared by 148.21% to $3.7 million in 2024, then tumbled by 136.51% to -$1.3 million in 2025.
  • Business Quant data shows Change in Cash for HCWB at -$1.3 million in Q3 2025, $1.3 million in Q2 2025, and -$3.6 million in Q1 2025.